Corporate Venture Investing & Minority Stakes

A minority investment buys a share of a company's economics and a set of negotiated rights. It need not bring the control an acquirer uses to integrate a business. Corporate venture capital (CVC) uses such stakes to reach emerging capabilities, open commercial relationships, and learn, while also seeking a financial return. It works when the company decides at the start which of those outcomes it is paying for and how it will measure each.

For CorpDev, the discipline is to invest only when holding equity improves the intended outcome. A pilot, a license, a distribution agreement, or a full acquisition may solve the problem more directly. A small equity check should never stand in for choosing a strategy.

Write the investment mandate before meeting companies

The mandate sets three things:

• Where to invest: strategic domains, company stages, and geographies
• How much: approval authority for each check, ownership targets, risk limits, and follow-on policy
• Who decides: the named decision makers

State whether the program puts financial returns, commercial value, or strategic learning first, or combines them under explicit rules. Never change the objective after an investment disappoints on the original measure.

Where it helps, name two owners. The investment lead is accountable for the economics and portfolio governance. The business sponsor is accountable for the commercial or strategic work. Require a continuity plan in case the sponsor leaves or the business unit's priorities change.

The table lists the questions a mandate must answer.

Six more documents follow from the mandate:

• The investment memo
• A capitalization and outcome model
• A plain-language rights summary
• A commercial plan
• A follow-on policy
• The portfolio review

Check whether a contract or an acquisition would work better

A minority stake can suit a capability that is promising but too early, or too independent, to integrate. It can also support a strategic relationship while leaving the company free to serve a broad market. A full acquisition fits better when the value depends on controlling product priorities, assets, or integration, and the buyer can take on that responsibility.

Test a commercial-only route. If the goal is access to a product, the key terms may belong in a commercial contract rather than a share purchase. The reverse also holds: a stake bought for financial exposure should be judged on its investment merits, however attractive the commercial relationship.

Be careful about calling a stake a cheap option to buy the company later. That holds only if the actual rights, future financing, other shareholders, and circumstances support it. A relationship today guarantees neither a future sale nor an acceptable future price.

Diligence both the company and the security you buy

Review the business (product, customer evidence, and team), its finances (cash runway and financial plan), and its risks (intellectual property, dependencies, and significant liabilities). Match the depth of diligence to your exposure and influence, not only to the size of the first check. A small investment can still bring significant commercial, reputational, information, or governance obligations.

The table links each area of diligence to the decision it informs.

Have transaction counsel assess the actual rights and responsibilities for this company, this security, and the jurisdictions involved. Keep a plain-language rights summary that the investment team and the business sponsor can work from after closing.

Model what the stake pays out, not the headline valuation

Build a fully diluted ownership model through plausible later financing rounds. Include changes to the option pool, convertible instruments, your own follow-on participation, and a range of exit values. Then model the distribution waterfall, the order in which sale proceeds are paid to each class of shareholder, using the actual terms of each security.

A quoted ownership percentage can misstate what a stake receives. The hypothetical example below assumes a $10 million investment for 20% of the company in preferred shares. The shares carry a 1x non-participating liquidation preference. On a sale, the holder receives the larger of its $10 million back or 20% of the proceeds, capped at what the sale raises. The example assumes no other preferred shares, no debt, and no transaction costs.

Above a $50 million sale price, the preference stops mattering. Participation rights, preferences above 1x, and the ranking of different funding rounds all change these numbers, which is why diligence asks for the actual terms.

Treat the company's value and your security's value as separate questions. Analyze downside, flat, growth, and additional-funding cases. Compare the cash returned, and when it arrives, with all capital invested, including follow-ons. An unrealized mark-up is not cash.

Set a valuation policy with finance and accounting specialists. It should cover the evidence required, how often values are reviewed, signs of impairment where they apply, and how later financing rounds are treated. A new round's price is relevant evidence, but read it in light of the round's terms and the company's condition.

Put commercial rights in commercial contracts

Write the commercial terms into the commercial agreements. They cover what your company can use (product access, pilots, data, and intellectual property), on what terms (pricing, service levels, implementation, and exclusivity), and how the arrangement ends. Rights you hold as a shareholder, such as information rights, do not give you product access or delivery commitments.

Weigh how strategic restrictions affect the investee's ability to sell its products, form partnerships, raise money, and give its investors an exit. Broad exclusivity or heavy information demands can undermine the growth the investment depends on. So can a right of first refusal, which lets your company match any offer before shares or the company are sold to someone else. Ask for rights in proportion to what your company actually needs, and model the trade-off. No additional right comes free.

When your company is at once a customer, supplier, shareholder, or potential acquirer, set procedures for conflicts. Counsel should define how information is handled, how board participation works, when a board member steps aside from a decision, and which commercial processes apply. The business sponsor should know which information may be used for which decisions.

Set the follow-on policy with the first check

At the first approval, state whether your company expects to join future funding rounds, how much capital is reserved, and the criteria for investing. Keep two motives apart: protecting your ownership, and investing more because the new round is attractive. Underwrite each new check on its own merits.

Compare the investee's cash runway with the milestones that create value. If it needs money before reaching a product or customer milestone, work out what happens if you participate, decline, or provide temporary support. A bridge financing (short-term money to reach the next round) needs fresh underwriting and explicit authority.

Across the portfolio, test whether several companies could need funding at the same time. Money, sponsor attention, and specialist support can all run short together. Keep room for surprises instead of committing the whole program to first checks.

Example: a $10 million stake with no launch plan

This example is fictional. A company invests $10 million in a software company to speed up a new customer workflow. The investment memo assumes a commercial launch within a year. After approval, the business unit discovers that nobody owns or has budgeted the security review, the product integration, or the preparation of its sales team.

A better approval would have linked two plans, each judged on its own terms.

The committee should be able to see both results, and neither should be used to excuse the other.

Judge financial and strategic results separately

Keep two scorecards for the portfolio, and keep them apart.

Keep a learning log for each investment

The strategic scorecard is the hard one to fill. What an investment has taught the business is scattered across quarterly board decks, founder update letters, pilot reports, and the sponsor's memory. When the sponsor moves on, much of it leaves too. The valuation mark, meanwhile, is updated regularly, so it tends to drive the decision to scale, hold, or exit by default.

For each investment, compare the original hypotheses with dated evidence from pilots, operating reviews, and permitted investor materials. Record which business decisions the evidence changed. Confirm that the company may use each document for this purpose; shareholder information can carry restrictions, particularly where the investee competes with a business unit.

A useful log is short, dated, and blunt. A hypothetical example:

The log in this excerpt recommends holding the stake and releasing no follow-on capital until a second pilot reports.

Bring the logs to the portfolio review next to the financial scorecard, and discuss the two separately. A relationship earns more sponsor time and budget when its hypotheses hold up and it has changed real decisions. An investment that has changed no decision is a financial holding, and should be judged as one.

The check that matters: open a few cited documents at random and confirm the evidence is there. Watch in particular for a company forecast recorded as a result.

Plan exits and ownership changes in advance

Keep a playbook for exits and changes of ownership. It should cover transfer provisions, likely buyers, and how the commercial relationship would continue. It should also set who may see which information, and how to handle conflicts if your company considers buying the investee.

Treat any proposal to acquire an investee as a new M&A decision. It needs fresh underwriting and proper governance, including the effects of the existing stake and relationships.

Where to go next

Continue with the strategic framework for M&A, deal structure overview, and approval gates.